RYTM — Rhythm Pharmaceuticals Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Rhythm Pharmaceuticals Inc (RYTM), worth $214.90M combined. Over the quarter 2 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $184.71M | 0.52% | +3% |
| Duquesne | $22.61M | 0.52% | NEW |
| Renaissance | $7.58M | 0.01% | -73.5% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.